Comparison of left ventricular function and infarct size in patients with and without persistently positive technetium-99m pyrophosphate myocardial scintigrams after myocardial infarction: analysis of 357 patients.

[1]  A. Abdulla,et al.  Detection of unstable angina by 99m technetium pyrophosphate myocardial scintigraphy. , 1976, Chest.

[2]  P Richards,et al.  A simple kit for the preparation of 99mTc-labeled red blood cells. , 1976, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[3]  E. Stokely,et al.  A new method for radionuclide imaging of myocardial infarcts. , 1974, Radiology.

[4]  R W Parkey,et al.  Myocardial infarct imaging with technetium-99m phosphates. , 1977, Seminars in nuclear medicine.

[5]  J. Willerson,et al.  Sites and mechanisms of localization of technetium-99m phosphorus radiopharmaceuticals in acute myocardial infarcts and other tissues. , 1977, The Journal of clinical investigation.

[6]  Malin Fr,et al.  Sequential Myocardial Scintigraphy with Technetium-99m Stannous Pyrophosphate Following Myocardial Infarction , 1978 .

[7]  E. Stokely,et al.  Gated blood pool imaging following 99mTc stannous pyrophosphate imaging. , 1976, Radiology.

[8]  E. Stokely,et al.  A New Method for Radionuclide Imaging of Acute Myocardial Infarction in Humans , 1974, Circulation.

[9]  E. Stokely,et al.  Infarct sizing with technetium-99m stannous pyrophosphate scintigraphy in dogs and man; relationship between scintigraphic and praecordial mapping estimates of infarct size in patients. , 1977, Cardiovascular Research.

[10]  J. Mason,et al.  Technetium-99m pyrophosphate myocardial uptake in patients with stable angina pectoris. , 1977, The American journal of cardiology.

[11]  J. Willerson,et al.  Clinicopathologic findings in 52 patients studied by technetium-99m stannous pyrophosphate myocardial scintigraphy. , 1979, Circulation.

[12]  R. Roberts,et al.  Radioimmunoassay of creatine kinase isoenzymes. , 1976, Methods in enzymology.

[13]  R. Jennings,et al.  Myocardial calcium and magnesium in acute ischemic injury. , 1972, The American journal of pathology.

[14]  B. Sobel,et al.  Rapid separation of plasma creatine kinase isoenzymes by batch adsorption on glass beads. , 1975, Clinical chemistry.

[15]  M. Ahmad,et al.  Technetium 99m Stannous Pyrophosphate Myocardial Imaging in Patients with and without Left Ventricular Aneurysm , 1976, Circulation.

[16]  H R Schelbert,et al.  Left ventricular ejection fraction--a review of several radionuclide angiographic approaches using the scintillation camera. , 1978, Progress in cardiovascular diseases.

[17]  K. Hisada,et al.  [Technetium-99m stannous pyrophosphate myocardial scintigraphy]. , 1983, Rinsho hoshasen. Clinical radiography.

[18]  R. Dinsmore,et al.  Observer Variance in the Qualitative Evaluation of Left Ventricular Wall Motion and the Quantitation of Left Ventricular Ejection Fraction Using Rest and Exercise Multigated Blood Pool Imaging , 1980, Circulation.

[19]  P. Raskin,et al.  Increased incidence and clinical correlation of persistently abnormal technetium pyrophosphate myocardial scintigrams following acute myocardial infarction in patients with diabetes mellitus. , 1982, American heart journal.

[20]  E. Stokely,et al.  Morphologic Correlates of Technetium‐99m Stannous Pyrophosphate Imaging of Acute Myocardial Infarcts in Dogs , 1975, Circulation.

[21]  E. Stokely,et al.  Acute subendocardial myocardial infarction in patients. Its detection by Technetium 99-m stannous pyrophosphate myocardial scintigrams. , 1975, Circulation.

[22]  M. Devous,et al.  A comparison of infarct identification with technetium-99m pyrophosphate and staining with triphenyl tetrazolium chloride. , 1983, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[23]  D. Stewart,et al.  Left Ventricular Function Before and Following Aortic Valve Replacement , 1977, Circulation.

[24]  B. Sobel,et al.  An Improved Basis for Enzymatic Estimation of Infarct Size , 1975, Circulation.

[25]  D G Pavel,et al.  In vivo labeling of red blood cells with 99mTc: a new approach to blood pool visualization. , 1977, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[26]  M. A. Douglas,et al.  High temporal resolution ECG-gated scintigraphic angiocardiography. , 1975, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[27]  R. Okada,et al.  Early changes in left ventricular size and function after correction of left ventricular volume overload. , 1981, The American journal of cardiology.

[28]  P. Cohn,et al.  Augmentation of Left Ventricular Contraction Pattern in Coronary Artery Disease by an Inotropic Catecholamine: The Epinephrine Ventriculogram , 1974, Circulation.

[29]  W. Aronow,et al.  Follow-up Technetium-99m Stannous Pyrophosphate Myocardial Scintigrams after Acute Myocardial Infarction , 1977, Circulation.

[30]  E. Braunwald,et al.  The Stunned Myocardium: Prolonged, Postischemic Ventricular Dysfunction , 1982, Circulation.

[31]  W. Parmley,et al.  The specificity of pyrophosphate myocardial scintigrams in patients with prior myocardial infarction: concise communication. , 1978, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[32]  J. Willerson,et al.  Pathophysiologic considerations and clinicopathological correlates of technetium-99m stannous pyrophosphate myocardial scintigraphy. , 1980, Seminars in nuclear medicine.

[33]  B. Pitt,et al.  The combined use of Gated Cardiac Blood Pool Scanning and Myocardial Imaging with Postassium-43 in the Evaluation of Patients with Myocardial infarction. , 1975, Radiology.

[34]  J. Kuperus,et al.  Prognostic value of a persistently positive technetium-99m stannous pyrophosphate myocardial scintigram after myocardial infarction. , 1979, The American journal of cardiology.

[35]  J. Willerson,et al.  Clinicopathologic Study of Persistently Positive Technetium-99m Stannous Pyrophosphate Myocardial Scintigrams and Myocytolytic Degeneration After Myocardial Infarction , 1977, Circulation.

[36]  D. An.  AN ELECTRON MICROSCOPIC STUDY OF CARDIAC NECROSIS PRODUCED BY 9 ALPHA-FLUOROCORTISOL AND SODIUM PHOSPHATE. , 1964 .

[37]  R. Kerber,et al.  Present status of the 99m technetium pyrophosphate infarct scintigram. , 1977, Circulation.

[38]  E. Stokely,et al.  Measurement of acute myocardial infarcts in dogs with 99mTc-stannous pyrophosphate scintigrams. , 1976, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[39]  W. Rogers,et al.  Technetium-99m Stannous Pyrophosphate Myocardial Scintigraphy: Reliability and Limitations in Assessment of Acute Myocardial Infarction , 1977, Circulation.

[40]  E. Sonnenblick,et al.  Detection of Residual Myocardial Function in Coronary Artery Disease Using Post‐extra Systolic Potentiation , 1974, Circulation.

[41]  J. Willerson,et al.  Technetium stannous pyrophosphate myocardial scintigrams in patients with chest pain of varying etiology. , 1975, Circulation.

[42]  E. Stokely,et al.  Comparison of different noninvasive methods of infarct sizing during experimental myocardial infarction. , 1977, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.